Clinical Trial Update: Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on DA-2802 shows efficacy and safety in chronic hepatitis B patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• DA-2802

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Hepatitis B， Chronic | Phase 3 | Status: COMPLETED